For a number of people, starting their day with a cup of coffee is a must thing. In neonatal intensive care units (NICUs), premature babies born before completing their 29 Weeks are daily offered a caffeine dose. This therapy is given to ensure the best possible beginning to babies’ life. In the latest research carried out at the University of Calgary, researchers demonstrated that the earlier the caffeine dose is given, the better.
Dr. Abhay Lodha, MD, Associate Professor, Departments Of Paediatrics, and Community Health Sciences, Cumming School of Medicine, proclaimed that caffeine is the most widely employed drug in the NICU after antibiotics. He highlighted the need to understand the long-lasting effects of caffeine when employed as a treatment. He added that doctors should ensure the survival of these premature babies along with the quality of life they will get down the road.
On a similar note, recently, Rutgers University came into the news as it revealed the outcomes the latest study carried out. Researchers at Rutgers asserted that caffeine and another element in coffee beans’ waxy coating can be helpful in protecting a person from the health condition such as brain degeneration. Scientists revealed that they found a compound in coffee that can work together with caffeine to fight with the health issues such as Lewy body dementia and Parkinson’s disease. Both of these diseases are linked to brain degeneration and presently not curable.
The latest study is published in the journal the Proceedings of the National Academy of Sciences. It suggests that the combination of both these compounds can be used as a therapeutic option to achieve slowing down the process of brain degeneration. M. Maral Mouradian, Director at Rutgers Robert Wood Johnson Medical School Institute for Neurological Therapeutics, is heading this research.